Background-The risk factors for ventricular arrhythmias in patients with coronary vasospasm have not been identified.
L ife-threatening ventricular arrhythmias occur in 5% to 15% of patients with vasospastic angina. [1] [2] [3] [4] [5] [6] [7] These arrhythmias are associated with an increased incidence of cardiac events, including sudden death. [1] [2] [3] [4] [5] [6] [7] However, the factors that increase the risk for malignant ventricular arrhythmias have not been identified in patients with vasospastic angina.
Measurement of the variability in the duration of the QT interval among different leads of a standard 12-lead ECG has been proposed as a noninvasive method to detect inhomogeneity of ventricular recovery times and arrhythmogenic potential. 8 -11 Prolonged QT dispersion is associated with an increased risk of serious ventricular arrhythmias in patients with the long QT syndrome, [12] [13] [14] hypertrophic cardiomyopathy, 15 chronic heart failure, 16 and myocardial infarction. [17] [18] [19] However, no previous studies have examined QT dispersion in patients with vasospastic angina and its relation to susceptibility to arrhythmias. We recently reported that patients with vasospastic angina exhibit increased ventricular vulnerability, even during an asymptomatic phase. This increased vulnerability may predispose them to the development of malignant ventricular arrhythmias aggravated by vasospastic events. 20 This study was designed to test the hypotheses that patients with vasospastic angina exhibit an increase in QT dispersion and that QT dispersion is related to the susceptibility to ventricular arrhythmias in these patients.
Methods

Study Patients
We studied 50 consecutive patients with vasospastic angina (29 men and 21 women; mean age 58 years, range 44 to 71 years) evaluated at Yokohama Minami Kyosai Hospital. All patients exhibited myocardial ischemic ST-segment changes, either ST elevation or ST depression, associated with spontaneous episodes of chest pain on ambulatory Holter monitoring and/or a 12-lead ECG. After intracoronary injection of acetylcholine, they were classified angiographically as having total occlusion, subtotal occlusion (99% with delay), or diffuse vasoconstriction (Ͼ90%) associated with chest pain and/or myocardial ischemic ST-segment changes. 21 We also studied 50 patients with atypical chest pain (28 men and 22 women; mean age 57 years, range 45 to 70 years) in whom no spontaneous chest pain was documented by ambulatory Holter monitoring and/or ECG and who showed no ischemic ST-segment changes with chest pain on an exercise test. These patients were referred for evaluation with a provocation test with acetylcholine and were matched to the patients with vasospastic angina for age, sex, and body mass index.
Both groups had normal results on physical examination and no history of cardiac disease, overt diabetes mellitus, chronic obstructive lung disease, renal disease, or endocrine disorders. None of the patients had abnormalities on resting 12-lead ECGs, 2-dimensional echocardiograms, or Doppler echocardiograms. No patient was receiving antiarrhythmic agents or other types of therapy that can affect the QT interval.
The study protocol was approved by the ethics committee at our institution. Written informed consent was obtained from all subjects.
Angiographic Analysis
Coronary arteriography was performed by the Judkins technique in the morning while patients were fasting and unsedated. Antianginal drugs, except for sublingual nitroglycerin, were discontinued at least 3 days before the study. Baseline coronary arteriography was performed in the right anterior oblique projection for the left coronary artery and in the left anterior oblique projection for the right coronary artery. A bipolar electrode catheter was inserted into the right ventricular apex through the right femoral vein and connected to a temporary pacemaker. The pacing rate was set at 50 bpm. Incremental doses of acetylcholine were injected into the left coronary artery (20, 50 , and 100 g) and the right coronary artery (20, 50 , and 70 g) until acetylcholine-induced total, subtotal, or diffuse vasoconstriction was detected angiographically or until the maximum dose was given. 21 After the injection of 1.0 mg of isosorbide dinitrate into the left and right coronary arteries, arteriograms were obtained in several projections and the organic coronary artery lesion was evaluated. Coronary arteriography was performed again 30 minutes after the relief of vasospasm to confirm the absence of significant stenosis.
QT Interval and QT Dispersion of a 12-Lead Surface ECG
The QT interval and QRS duration were measured in all leads of a 12-lead ECG recorded at a speed of 50 mm/s for 2 consecutive cycles. The QT interval was measured from the beginning of the QRS complex to the end of the T wave, which was defined as the return to the TP baseline (between the end of the T wave and the following P wave); the U wave was excluded. None of the 100 study subjects had a U wave superimposed on the terminal portion of the T wave. If the T wave could not be reliably determined or if it had a very low amplitude, QT measurements were not obtained, and these leads were excluded from the analysis. The QT interval was measurable in 9 to 12 leads (mean 11Ϯ1 leads) in each subject. The mean QT interval was calculated as the average of all measurable leads.
QT dispersion, defined as the difference between the maximum and minimum QT intervals, was determined with previously described methods. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] Both the QT interval and QT dispersion were rate-corrected with a modification of Bazett's formula as follows: QTc intervalϭQT/square root of the RR interval. 22 Measurements were obtained at baseline (before intracoronary injection of acetylcholine) and 30 minutes after intracoronary injection of isosorbide dinitrate (when chest pain and ischemic ST changes were not observed). Because the effect of acetylcholine disappears within minutes, we considered an interval of 30 minutes between the relief of coronary vasospasm and the measurement of QT intervals to be long enough to allow full recovery of any electrophysiologic properties that might be affected by acetylcholine. 21, 23, 24 An ECG was monitored continuously to record the incidence of arrhythmias.
Statistical Analysis
Data are expressed as the mean valueϮSD, mean differencesϮSD (MD), and 95% confidence interval of mean difference (CI). The two-tailed paired Student's t test was used to analyze changes in the QTc interval, QTc dispersion, and hemodynamic variables. Between-group comparisons were made with the two-tailed unpaired Student's t test. Multiple comparisons of continuous variables were performed by ANOVA. Fisher's exact probability test or the 2 test was used to evaluate group differences in categorical variables. A P value Ͻ0.05 was considered to indicate statistical significance. The reproducibility of the QT dispersion measurements was examined in 50 patients with vasospastic angina at baseline and after the relief of vasospasm by 2 independent experienced observers who were unaware of the patient's diagnosis. Agreement between observers was verified with the Bland-Altman method. 25 
Results
Patient Characteristics and Angiographic Results
There were no significant differences in baseline characteristics between groups ( Table 1) .
None of the patients with atypical chest pain showed significant vasospasm (Ͼ50%) or ischemic ST-segment changes at baseline or after intracoronary injection of acetylcholine. The total coronary vasomotor response to acetylcholine, defined as the percent decrease in the luminal diameter, ranged from Ϫ10% to 50% (31.1Ϯ3.0%) in patients with atypical chest pain.
In patients with vasospastic angina, no chest pain or myocardial ischemic ECG changes were observed at baseline. A spontaneous 25% vasoconstriction of the right coronary artery was observed in 4 patients and 25% vasoconstriction of the left anterior descending artery was observed in 4 patients. One patient showed 50% vasoconstriction of the right coro- Values are expressed as meanϮSD or number of patients.
nary artery but did not exhibit ischemic ECG changes or chest pain. The remaining 41 patients had normal coronary arteries at baseline coronary angiography.
All 50 patients with vasospastic angina developed severe vasoconstriction and typical ischemic symptoms in response to acetylcholine. Vasospasm of multiple coronary arteries was induced in 19 of 50 patients; single coronary artery vasospasm occurred in the remaining 31 patients. Total occlusion was induced in 22 vessels of 16 patients, subtotal occlusion in 25 vessels of 19 patients, and diffuse constriction in 29 vessels of 25 patients.
The acetylcholine-induced symptoms and ECG changes were completely relieved by the injection of isosorbide dinitrate; there was no significant residual stenosis. All patients with vasospastic angina also exhibited normal coronary arteries, without stenosis, 30 minutes after administration of isosorbide dinitrate. There were no major complications relating to the injection of acetylcholine, either in the catheter laboratory or after catheterization.
Reproducibility of QT Dispersion Measurements
The mean difference between observers in the measurement of baseline QT dispersion (nϭ50) was 0Ϯ4 ms and 95% CI was between -1 and 1 ms. After the relief of vasospasm, the mean difference between observers was 0Ϯ5 ms and 95% CI was between -1 and 1 ms (Figure 1 ).
QTc Intervals and QTc Dispersion on Surface ECGs
The mean heart rate increased significantly after the relief of coronary vasospasm compared with the baseline value in both groups (vasospastic angina, meanϮSD: 70Ϯ14 versus 76Ϯ15 bpm, MD: Ϫ6.0Ϯ15 bpm, CI: Ϫ10 to Ϫ2 bpm, PϽ0.01; atypical chest pain, meanϮSD: 71Ϯ14 versus 76Ϯ14 bpm, MD: Ϫ5Ϯ13 bpm, CI: Ϫ8 to Ϫ1 bpm, PϽ0.01). Systemic arterial pressure did not change significantly after the relief of vasospasm in either group (vasospastic angina, meanϮSD: 125Ϯ22 versus 120Ϯ20 mm Hg, MD: 5Ϯ22 mm Hg, CI: Ϫ2 to 10 mm Hg; atypical chest pain, meanϮSD: 124Ϯ21 versus 119Ϯ20 mm Hg, MD: 5Ϯ29 mm Hg, CI: Ϫ3 to 13 mm Hg). There was no significant difference in the mean QRS interval between patients with vasospastic angina and patients with atypical chest pain. In patients with vasospastic angina, the QRS interval at baseline was 74Ϯ19 ms; after the relief of coronary vasospasm, it was 74Ϯ17 ms (MD: 0Ϯ5 ms, CI: Ϫ1 to 2 ms). In patients with atypical chest pain, it was 74Ϯ16 ms at baseline and after injection of isosorbide dinitrate (MD: 0Ϯ5 ms, CI: Ϫ1 to 2 ms).
The QTc interval was significantly smaller at baseline than that after the relief of coronary vasospasm in patients with vasospastic angina (Table 2 ). The baseline QTc dispersion was significantly greater in patients with vasospastic angina than in patients with atypical chest pain (meanϮSD: 69Ϯ24 ms versus 44Ϯ19 ms, MD: 25Ϯ30 ms, CI: 16 to 33 ms; PϽ0.001) (Figure 2 ). QTc dispersion decreased significantly, to 48Ϯ15 ms (MD: 21Ϯ20 ms, CI: 15 to 26 ms; PϽ0.001 versus baseline) after administration of isosorbide dinitrate in patients with vasospastic angina but did not change significantly in patients with atypical chest pain (meanϮSD: 41Ϯ17 ms, MD: 3Ϯ22 ms, CI: Ϫ3 to 9 ms) (Figure 2 ).
Ventricular Arrhythmias in Patients With Vasospastic Angina
Ventricular arrhythmias occurred in 24 of 50 patients with vasospastic angina only during the provocation test. Polymorphic nonsustained ventricular tachycardias lasting at least 3 consecutive beats were observed in 5 of 24 patients. The remaining 19 patients had less serious ventricular arrhyth- mias, including isolated premature ventricular contractions, bigemini, and couplets. All ventricular arrhythmias were observed when the patients had ischemic symptoms after the administration of acetylcholine and no ventricular arrhythmias were observed immediately after intracoronary injection of isosorbide dinitrate. At baseline, QTc dispersion was significantly greater in patients with than without ventricular arrhythmias (meanϮSD: 77Ϯ23 ms versus 61Ϯ19 ms, MD: 16Ϯ26 ms, CI: 4 to 26 ms; PϽ0.05) (Figure 3 ). QTc dispersion did not differ significantly between these subgroups after the relief of coronary vasospasm (meanϮSD: 47Ϯ14 versus 48Ϯ14 ms, MD: Ϫ1Ϯ20 ms, CI: Ϫ8 to 9 ms) (Figure 3 ).
There were no significant differences in baseline patient characteristics or the severity of vasospasm between patients with vasospastic angina with and without ventricular arrhythmias.No patients with atypical chest pain showed ventricular arrhythmias during the provocation test.
Discussion
In the present study, patients with vasospastic angina exhibited greater baseline QTc dispersion than patients with atypical chest pain. Increased QTc dispersion in asymptomatic patients with vasospastic angina was associated with increased vulnerability to ventricular arrhythmias related to ischemic events. These findings suggest that patients with vasospastic angina have increased dispersion of ventricular repolarization, which may increase the risk of sudden death caused by malignant arrhythmias. [1] [2] [3] [4] [5] [6] [7] The present findings support previous reports demonstrating that subsets of patients with increased QT dispersion are at increased risk of sudden cardiac death. 8 -19 
QT Dispersion in Patients With Vasospastic Angina
To the best of our knowledge, this study is the first to evaluate QT dispersion in patients with vasospastic angina. QT dispersion reflects the regional variation in ventricular repolarization, which is an electrophysiologic substrate for the genesis of arrhythmias. QT dispersion has been proposed as a marker of arrhythmogenic potential. 8 -19 In this study, the baseline QTc dispersion was significantly increased in patients with vasospastic angina without evidence of myocardial ischemia or angiographically detectable coronary artery spasm. After the relief of vasospasm by isosorbide dinitrate, QTc dispersion decreased significantly to the level similar to that in patients with atypical chest pain. These data suggest that patients with vasospastic angina have greater inhomogeneity of repolarization, independent of the presence or absence of ischemic symptoms.
Sudden Death in Patients With Vasospastic Angina
Fatal ventricular arrhythmias have frequently been documented in patients with ischemic heart diseases, including vasospastic angina, exertional angina, and myocardial infarction. [1] [2] [3] [4] [5] [6] [7] Previous studies have shown that the occurrence of ventricular arrhythmias depends on the magnitude of the dispersion in the refractory period. Inhomogeneity and increased dispersion of repolarization may promote polymorphic ventricular tachycardia and ventricular fibrillation. 20,26 -31 The development of ventricular arrhythmias in patients with vasospastic angina is thought to be caused not only by reentry associated with myocardial ischemia during vasospasm but also by reentry and/or triggered activity associated with reperfusion after the relief of spasm. 6 -10,20,32-34 In this study, 24 of 50 patients with vasospastic angina experienced ventricular arrhythmias, including ventricular tachycardia. Arrhythmias were observed during induced ischemia but not immediately after the relief of spasm by the administration of isosorbide dinitrate (assumed to be a reperfusion period). This may partly be due to the very short period of myocardial ischemia induced by the provocation test. QTc dispersion at baseline was significantly greater in patients with than without ventricular arrhythmias. There was no difference in the degree or severity of coronary vasospasm between patients with and without ventricular arrhythmias. The greater QTc dispersion in patients with vasospastic angina who developed ventricular arrhythmias during induced ischemia may indicate that the dispersion of ventricular refractoriness was increased in the asymptomatic state, due to abnormal microcirculation 35 or autonomic dysfunction. 36, 37 These findings suggest that evaluation of QTc dispersion may provide useful information about baseline abnormalities of ventricular repolarization and susceptibility to ventricular arrhythmias caused by ischemia in patients with vasospastic angina.
We recently reported that the effective refractory period for right ventricular sites is short and that electrophysiologic instability is present in patients with vasospastic angina, even when asymptomatic. 20 The results of the present study support these previous findings. Thus the measurement of QTc dispersion obtained in the nonmedicated, asymptomatic state appears to be a simple, noninvasive method of obtaining information about the susceptibility of patients with vasospastic angina to ventricular arrhythmias.
Study Limitations
The relation between the incidence of ventricular arrhythmias during the ischemic state and the prognosis of these patients remains to be determined.
This study did not directly demonstrate a higher risk of sudden death in these patients. However, in a previous study from our laboratory, patients with ventricular arrhythmias during induced myocardial ischemia had a higher incidence of ventricular tachycardia induced by programmed stimulation, 20 suggesting that the risk of lethal cardiac events was increased in these patients.
Conclusions
QTc dispersion was increased in asymptomatic patients with vasospastic angina compared with patients with atypical chest pain, indicating that patients with vasospastic angina had greater inhomogeneity of ventricular refractoriness, which may predispose them to life-threatening arrhythmias, even in the absence of signs of ischemia. The relation between increased QT dispersion and the incidence of ventricular arrhythmias during myocardial ischemia in patients with vasospastic angina suggests that the simple, noninvasive measurement of QT dispersion may help identify patients at an increased risk of malignant arrhythmias. The prognostic implications should be evaluated in prospective follow-up studies.
